Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Snooze, wake us up in September Leo... Always 3 months out or longer with IPIX...
There’s no such thing as a naked short squeeze. They aren’t positions held before or after close like legit short shares which is around 2 million. Really a nothing burger to keep harping on an event that takes place on up and down days. If anything, it’s the markets allowance to not regulate the extreme bid/ask gap we see on most days. Send Leo a letter to move off their lame market.
Yesterday's news was Leo's way of filling the 10 week news void until data. Expect more fluff as the wait proceeds. Would rather see news on emergency use being the focus not treating other variants in 2025.
The grave concern is the amount of time it's taking for final data as revenue potential continues to slide... The vaccines are putting the B dream to rest... Leo's comments last-week did not offer much inspiration or excitement except for continued lab testing...
Moderna 220 in dollars, IPIX 21 in cents... The investment world has spoken... Leo had a chance but blew it by not running interim and get the ball rolling... Always, next month, 60 days, 4 months and so on.....
They would have data for 60 subjects if Leo was so confident... Doesn't appear he's in a hurry to plan for a P3... Again, EU is the only payout to shareholders worth the 16 month wait...
Heading to .18!!! No reason to own this unless one is brave into results... And that's 10 weeks away.
There’s no urgency for results with a GMU presentation in mid July and still no partner or grant money... Leo will use up the summer to prepare for the worst as he’s sure as heck not planning for the best. Expect fluff PRs for the virtual show with a corporate update sprinkled in describing how great the pipeline is!
No interim data shows little confidence and surely does not promote a future for B to C other than continued lab testing. Still waiting for Leo to mention EU or P3... SHHHH, cmon Leo you brought up treating other variants and the common cold? This 2 person operation is finished if results miss!!! Although, there will be suckers who will buy sub penny!!!
Yes, also don’t overlook the K for cancer, B for OM and Absssi markets as all 3 stay shelved losing patent time. The conman Leo keeps fooling the few who believe.
Stock should not have been rallying in the first place. Everyone new when 100 percent enrollment would be. Leo’s comments caused the decline.
The market makers giveth taketh away... The low volume rise made little sense as well... Everyone knew when full enrollment would be Leo made sure of that... Was a blow to find out it will take until Sept for results... That sort of crushes hopes for a phase 3 completing anytime soon... Back to sleep IPIX for the summer. Leo can enjoy hot FLA by-the-pool...
Moderna breaks 200, IPIX can't break 23 cents... The Gold Standard has done wonders promoting B to the world!!!
They wouldn't want bad data ahead of a presentation... The next 10 weeks will be filled with GMU's statement about B!!! Stay tuned!!! Just another broken record B for C...
Agree, Leo fumbled another opportunity with too many press releases on enrollment and when they finally reach 100 percent who freggen cares. And to top it off, zero mention about emergency use or phase 3... Hell, he didn't seem excited at all. Other variants in 2075 we'll be there... Phase 2 pharma is what we strive for!!!!
Teens today? No surprise, the pretend CEO's recap yesterday really deflated the 100 percent news. Shareholders wanted to see emergency use or phase 3 excitement, not we'll continue to develop B for future variants... FU shareholders....
They ran interim for OM but not Covid? People are dying wouldn't you want to know data fpr 60 subjects by now? Is waiting until Sept for 120 going to be much different? Leo could be planning so much now if they knew how great B was? Their 60 plus press releases leave little doubt....
Company? 2 employees? It's obvious Leo will try to sell IPIX if the data is strong. Not buying the developing B narrative he continues to push...
Really, you honestly believe a phase 3 is possible when? They'll get a phase 3 rolling by December or January then take how long to run? A mid 2022 completion will not be worth the cost...
Yes, that's a plus but wouldn't hiring a few employees go a long way for investors forming an opinion on the direction? Kumar is gone, they left the trial manager go early and have yet to replace Dr B with no number 2 except maybe Jane? How can anyone take this structure serious? Leo, Stop with the development BS... So a Govt lab as you described "which is subject to debate" has still not gotten IPIX a
grant?
Correct, exactly what I've been posting for a year... P2 was a ploy to keep them alive knowing a P3 was never possible... With only 120 subjects emergency use is the only thing that saves them... Need blowout data and then an eager country to bring B to market... Earliest end of year? Phase 3 mid 2022 completion... Not running interim data was the biggest clue of no urgency to get the ball rolling with EU or P3.... They'd have data by now instead of September.
No, believe I covered all the highlights. Leo's excitement for 100 percent was so electrifying with 2 little sentences about the need to keep developing B for the next pandemic... Doesn't sound so confident to leave out emergency use or P3...
100 percent enrolment was a given after updating every 10 percent... Yesterday's decline was the continued focus on treating future virus's with zero mention of EU or P3. With a staff of 2 how can anyone take Leo serious pretending they have plenty of years to keep B developing? The only reason IPIX trades .23 is an immediate treatment for COV-19... If they do not receive emergency use or run a P3 it's light out... B for C will be shelved like the others (OM/ABSSSI/K/UP)
Surprised Leo didn't issue a 95 percent enrollment PR... He had to get the 90 percent one in there a week ahead of 100... Why nobody takes this investment serious, the self-appointed CEO surely doesn't. Kips has 9 more weeks to dump the rest.....
Dead money here until mid August... Leo surely killed the little parade to .285... He's so confident in B for C that he was reluctant to do interim data to get the ball rolling with emergency use or phase 3 planning... We do have the GMU RBL one sentence conference in 6 weeks!!! Exactly why the staff of 2 stays current... No need to hire with all the excitement!!!
Retail buys? The past 3 weeks has averaged barely a million shares per/day which adds up to a whopping 230K daily... The volume was not enough to warrant the rise... I'll get excited when 10 million trade like last June... This stock is going nowhere until conman Leo describes his post data plans. Yesterday's PR provided very little except they plan to keep developing B for future viruses... Yawn..... No mention of emergency use? From the same "pretend CEO" who brought up the common cold last summer? LOL
No reason to buy or own shares until a week before results. The delay until September was why interim results were needed to speed up any plans for Covid emergency or phase 3... Today's PR casts much future doubt except they may have good results like Absssi, UP and OM... Broken record here!!! Mentioning the need to treat further variants was the clue... The focus needed to be on Covid not years away... Back to the teens she goes...
Timber... Nice job commander Leo!!! We are eager to get data for the next pandemic... We will continue to develop B with a staff of 2.
Yes, I'm sure GMU will dedicate an entire hour on Teams or Zoom to promote science that's still pending trial data.. Another nothing burger like the other conferences. Could you imagine GMU praising B and then results miss? Leo will now promote the conference to fill 12 more weeks of nothing to report on.
The past 16 months was to develop B for the next century to combat other virus's that may form after CV19... Boy, now we know why the stock trades toilet levels... No hiring, no partner, no grant money and no strategy post results. A staff of 2 will keep the B train going...
Conference? It's virtual? LOL IPIX will have one sentence read and that will be the end... CTIX/IPIX have a history of conference hype leading to nothing.
IPIX only biotech to have a 90 percent PR followed by 100 percent a week later? Leo is catering to Kips..
Appears Leo's focus is the next pandemic in 2075... Today's PR is not what the shareholders wanted to read.. Data late August, early Sept? If they had deals lined up they would have ran an interim study...
Now we know why Leo is not hiring it's always next month, next year, next pandemic... Never anything about NOW!!! Our strategy after results wil be to push emergency use to countries that are in need and a phase 3 if required....
PJ, Leo's goal is exactly that... The focus is not on today's pandemic because all signs point to no phase 3 funding... Leo the craftsman is already kicking the can down to the next pandemic...
Buy the rumor, sell the news.. IPIX back to sleep mode after Leo's uninspiring PR...
Leo always ruins the party... Needed to see an emergency use push or phase 3 comments in the PR... One little sentence about being eager to see results... Sad...
Believe the rally is over... 2 to 3 more months for data and zero info on post results strategy... Going to be another OM/Absssi situation even if data is good... Who in October is going to partner for a trial that's forecast to complete in mid to late 2022? The entire world will be vaccinated by then, no return on investment...
How long will a phase 3 (500 -1000) take? Like I've said before, it's emergency use or shelved...
No mention of emergency use or phase 3 interesting.... Have to wait 8 to 10 weeks for data... If they did interim that would have saved 2 months for an indication to start planning... Not sure this climbs much, buy the rumor sell the news...